Photon-Counting CT for Diagnostic Imaging
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method for CT scans using photon-counting technology (CT Photon-Counting). The goal is to determine if this method provides clearer images for doctors to diagnose conditions. Participants should have recently had or be scheduled for a CT scan of the head, neck, heart, chest, abdomen, pelvis, or limbs. Those over 18 who meet these criteria might be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to advancements in medical imaging technology.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this device is safe for diagnostic imaging?
Previous studies have shown that photon-counting CT (PCCT) improves image quality while reducing radiation exposure, potentially making it safer than traditional CT scans. Research indicates that PCCT counts X-ray photons directly, preserving all information and enhancing accuracy.
No major safety problems have been reported with PCCT, which is encouraging for those considering joining a trial using this technology. However, it is important to remember that new technologies are still under study, and more data is needed to fully understand their safety in every situation.12345Why are researchers excited about this trial?
Researchers are excited about Photon-Counting CT for diagnostic imaging because it promises to enhance image resolution and reduce radiation dose compared to traditional CT scans. Unlike conventional CT technology, which uses energy-integrating detectors, photon-counting CT employs detectors that count individual photons. This allows for better differentiation of tissues and potentially earlier detection of diseases. Additionally, by improving image clarity while using less radiation, it could offer a safer and more precise option for patients who require frequent imaging.
What evidence suggests that photon-counting CT is effective for diagnostic imaging?
Research has shown that photon-counting CT scans, which participants in this trial will receive, improve medical imaging by providing clearer pictures with less radiation. Studies indicate that this technology offers better image details, helping doctors see tiny structures more clearly. It also reduces electronic noise, making the images less blurry. Importantly, photon-counting CT distinguishes between different types of tissues better than regular CT scans. These features suggest that photon-counting CT could be a more effective tool for accurately diagnosing medical conditions.13567
Who Is on the Research Team?
Brian Thomsen
Principal Investigator
GE Healthcare
Are You a Good Fit for This Trial?
This trial is for adults over 18 who can consent to participate and are scheduled or have had a CT scan of the head, neck, heart, chest, abdomen, pelvis, or extremities within the past 120 days or next 30 days.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Data Collection
Participants are scanned using the investigational Pluto Photon-Counting CT system to collect data for evaluation
Follow-up
Participants are monitored for safety and effectiveness after data collection
What Are the Treatments Tested in This Trial?
Interventions
- CT Photon-Counting
Find a Clinic Near You
Who Is Running the Clinical Trial?
GE Healthcare
Lead Sponsor
Fotis Vlachos
GE Healthcare
Chief Marketing Officer since 2024
PhD in Molecular Biology and Biochemistry from the University of Massachusetts, MBA from the Wharton School of the University of Pennsylvania
Peter J. Arduini
GE Healthcare
Chief Executive Officer since 2022
MBA from Northwestern University, BSc in Marketing from Susquehanna University
Stanford University
Collaborator